Protalix BioTherapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Protalix BioTherapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Protalix BioTherapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $5.65M, a 4.57% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.65M -$270K -4.57% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $5.73M -$76K -1.31% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $5.88M +$677K +13% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $5.91M +$822K +16.2% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $5.92M +$1.06M +21.9% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $5.81M +$1.04M +21.7% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $5.2M +$299K +6.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $5.09M +$127K +2.56% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $4.85M -$391K -7.46% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $4.77M -$637K -11.8% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $4.9M -$587K -10.7% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $4.96M -$607K -10.9% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $5.25M -$455K -7.98% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $5.41M -$271K -4.77% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $5.49M -$223K -3.9% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $5.57M -$110K -1.94% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $5.7M -$64K -1.11% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $5.68M -$179K -3.06% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $5.71M -$131K -2.24% Mar 31, 2020 10-Q 2020-06-01
Q4 2019 $5.68M +$5.68M Dec 31, 2019 10-K 2021-03-30
Q3 2019 $5.76M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $5.86M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $5.84M Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.